Amantadine for COVID-19

J Clin Pharmacol. 2021 Mar;61(3):412-413. doi: 10.1002/jcph.1802. Epub 2020 Dec 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amantadine / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • COVID-19 / epidemiology*
  • COVID-19 Drug Treatment*
  • Fatigue / drug therapy
  • Fatigue / epidemiology
  • Humans
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / epidemiology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / epidemiology
  • Surveys and Questionnaires*

Substances

  • Antiviral Agents
  • Amantadine